v3.26.1
Non-controlling interests - NCI impact 2023 (Details)
€ in Millions, R in Millions
1 Months Ended 12 Months Ended
Apr. 25, 2023
ZAR (R)
Apr. 25, 2023
EUR (€)
Jun. 30, 2023
ZAR (R)
Jun. 30, 2023
EUR (€)
Dec. 31, 2025
ZAR (R)
Dec. 31, 2024
ZAR (R)
Dec. 31, 2023
ZAR (R)
Disclosure of subsidiaries [line items]              
Cash consideration paid by the Group to NCI on voluntary offer         R (45) R 0 R (1,009)
Keliber              
Disclosure of subsidiaries [line items]              
Payments to acquire or redeem entity's shares R (1,009) € (50.2) R (103) € (5.2)     (1,009)
Cash consideration received from rights issue subscription by NCI             1,096
Cash consideration paid by the Group to NCI on voluntary offer             (103)
Net cash received by the Group             993
Net reattribution of equity (accumulated profit and foreign currency translation reserve)             (596)
Increase (decrease) in equity             1,097
Keliber | Equity attributable to owners of Sibanye-Stillwater              
Disclosure of subsidiaries [line items]              
Increase (decrease) in equity             397
Keliber | Accumulated profit/(loss)              
Disclosure of subsidiaries [line items]              
Increase (decrease) in equity             463
Keliber | Foreign currency translation reserve              
Disclosure of subsidiaries [line items]              
Increase (decrease) in equity             (66)
Keliber | Non- controlling interests              
Disclosure of subsidiaries [line items]              
Increase (decrease) in equity             700
Keliber | Payment eliminated on consolidation              
Disclosure of subsidiaries [line items]              
Payments to acquire or redeem entity's shares             R 1,009